全文获取类型
收费全文 | 994篇 |
免费 | 22篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 81篇 |
妇产科学 | 18篇 |
基础医学 | 63篇 |
口腔科学 | 1篇 |
临床医学 | 136篇 |
内科学 | 231篇 |
神经病学 | 70篇 |
特种医学 | 19篇 |
外科学 | 58篇 |
综合类 | 140篇 |
预防医学 | 52篇 |
眼科学 | 1篇 |
药学 | 133篇 |
中国医学 | 14篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 19篇 |
2022年 | 28篇 |
2021年 | 56篇 |
2020年 | 43篇 |
2019年 | 35篇 |
2018年 | 42篇 |
2017年 | 24篇 |
2016年 | 29篇 |
2015年 | 35篇 |
2014年 | 69篇 |
2013年 | 78篇 |
2012年 | 63篇 |
2011年 | 80篇 |
2010年 | 57篇 |
2009年 | 47篇 |
2008年 | 42篇 |
2007年 | 31篇 |
2006年 | 33篇 |
2005年 | 14篇 |
2004年 | 22篇 |
2003年 | 13篇 |
2002年 | 10篇 |
2001年 | 13篇 |
2000年 | 13篇 |
1999年 | 7篇 |
1998年 | 4篇 |
1996年 | 4篇 |
1995年 | 5篇 |
1994年 | 6篇 |
1993年 | 11篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 6篇 |
1987年 | 6篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 8篇 |
1983年 | 2篇 |
1982年 | 6篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 5篇 |
1974年 | 4篇 |
1972年 | 2篇 |
1969年 | 4篇 |
1968年 | 2篇 |
排序方式: 共有1020条查询结果,搜索用时 15 毫秒
1.
2.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
3.
《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2022,16(6):102525
BackgroundHypoglycemia unawareness designates failure to detect eminent hypoglycemia. Clarke's questionnaire is one of the most used systems to evaluate this problem.AimsTo relate Clarke's questionnaire (QQ) results with continuous glucose monitoring data.MethodsApplication of the questionnaire in a sample of type 1 diabetes mellitus (T1DM) patients using intermittent continuous glucose monitoring (iCGM).Results111 T1DM patients were evaluated, 56.8% female, mean age 35.0 ± 12.4 years and mean disease duration 18.8 ± 10.5 years.According to CQ, 13.5% had unawareness, 76.6% awareness and 9.9% indeterminate awareness to hypoglycemia. Those with unawareness had longer disease duration (25.1 ± 10.4 vs 18.2 ± 10.3 for awareness and 14.9 ± 9.9 for indeterminate awareness, p = 0.047), more time below range (10.3 ± 4.9% vs 6.3 ± 5.1 and 6.3 ± 4.8; p = 0.009) and higher mean duration of hypoglycemia (131.7 ± 38.6 vs 116.6 ± 49.6 and 131.7 ± 38.6; p = 0.008). In multivariate analysis, mean duration of hypoglycemia was an independent predictor of CQ results. In a receiver operating curve (AUC 0.746; p = 0.004) a mean duration of hypoglycemia ≥106.5 min showed 84.6% sensitivity/64.4% specificity for unawareness.ConclusionsOur sample had a significative prevalence of hypoglycemia unawareness which increased with longer diabetes duration. iCGM data can be indicative of this problem, with a mean hypoglycemia duration ≥106.5 min being suggestive, albeit unspecific. 相似文献
4.
5.
周素焕 《中国实用乡村医生杂志》2020,(2):42-44
目的探讨综合护理对糖尿病低血糖患者再发低血糖的几率的影响。方法选择2017年6月-2018年8月辽宁省人民医院接收的糖尿病低血糖患者100例为研究对象,随机分为观察组和对照组各50例。其中观察组实施综合护理,对照组实施常规护理,比较两组症状改善时间、住院时间、不良事件发生情况。结果观察组症状改善时间和住院时间均短于对照组,差异有统计学意义(P<0.05);观察组不良事件发生率低于对照组,差异有统计学意义(P<0.05)。结论对糖尿病低血糖患者应用综合护理可获得较好的护理效果,降低其再发低血糖的几率,值得临床推广应用。 相似文献
6.
7.
《Primary Care Diabetes》2022,16(3):417-421
AimsClinical inertia behaviour affects family physicians managing chronic disease such as diabetes. Literature addressing clinical inertia in the management of hypoglycemia is scarce. The objectives of this study were to create a measurement for physician clinical inertia in managing hypoglycemia (ClinInert_InHypoDM), and to determine physicians’ characteristics associated with clinical inertia.MethodsThe study was a secondary analysis of data provided by family physicians from the InHypo-DM Study, applying exploratory factor analysis. Principal axis factoring with an Oblimin rotation was employed to detect underlying factors associated with physician behaviors. Multiple linear regression was used to determine association between the ClinInert_InHypoDM scores and physician characteristics.ResultsFactor analysis identified a statistically sound 12-item one-factor scale for clinical inertia behavior. No statistically significant differences in clinical inertia score for the studied independent variables were found.ConclusionsThis study provides a scale for assessing clinical inertia in the management of hypoglycemia. Further testing this scale in other family physician populations will provide deeper understanding about the characteristics and factors that influence clinical inertia. The knowledge derived from better understanding clinical inertia in primary care has potential to improve outcomes for patients with diabetes. 相似文献
9.
10.
背景 糖尿病血液透析(HD)患者透析过程中易发生低血糖,尤其是无症状性低血糖,但目前关于糖尿病HD患者透析过程中发生低血糖影响因素的研究报道较少。目的 分析糖尿病HD患者透析过程中低血糖发生情况及其影响因素。方法 选取2017年1月-2019年12月在杭州市西溪医院血透中心行HD的糖尿病患者86例,均接受常规治疗、血糖控制治疗。监测所有患者在研究开始后1个月12次HD过程中(上机30 min内)血糖值,分析其低血糖发生情况及血糖变异性;糖尿病HD患者透析过程中发生低血糖的影响因素分析采用单因素分析和多元有序Logistic回归分析。结果 86例患者中40例未发生低血糖(未发组),24例发生1次低血糖(偶发组),22例发生≥2次低血糖(常发组),低血糖发生率为53.5%(46/86)。三组患者年龄、体质指数(BMI)、子女情况、文化程度、用药依从性、照顾能力、血糖平均值(MBG)、血糖变异系数(CVBG)比较,差异有统计学意义(P<0.05);多元有序Logistic回归分析结果显示,年龄增大〔OR=1.079,95%CI(1.000,1.160)〕、用药依从性差〔OR=13.250,95%CI(2.300,76.250)〕、照顾能力差〔OR=4.067,95%CI(1.090,15.300)〕、MBG<8.91 mmol/L〔OR=4.001,95%CI(1.250,12.850)〕是糖尿病HD患者透析过程中发生低血糖的危险因素,而BMI增大〔OR=0.776,95%CI(0.640,0.950)〕、CVBG<0.26〔OR=0.254,95%CI(0.080,0.790)〕是保护因素(P<0.05)。结论 糖尿病HD患者透析过程中低血糖发生率较高(为53.5%),年龄增大、用药依从性差、照顾能力差、MBG<8.91 mmol/L是糖尿病HD患者透析过程中发生低血糖的危险因素,而BMI增大、CVBG<0.26是保护因素。 相似文献